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ABSTRACT
Objective: The objective of this study is to analyze caspase-3 mRNA gene expression in a Wistar rat model of Alzheimer’s disease (AD) treated with 
Musa paradisiaca L. (MPL) ethanol extract or banana extract (BE)
Methods: MPL was evaluated for its effect on the caspase-3 mRNA gene expression of rat amyloid beta (Aβ) induced, an AD model. Each model 
included twenty Wistar rats were randomized into five groups: K0, without AD induction and no BE; K1, AD induction and no BE; K2, AD induction+BE 
250 mg/kg body weight (BW); K3, AD induction+BE 500 mg/kg; and K4, AD induction+BE 1000 mg/kg. AD induction was performed by Aβ1-42 (0.2 ug) 
injection at the intracerebroventricular area. mRNA caspase-3 level measurements were performed by real time-polymerase chain reaction.
Results: Paired t-test analysis showed no significant differences of caspase-3 mRNA level before Aβ induction among five groups (p>0.05). At 6 weeks 
post-Aβ induction, there was significantly increased caspase-3 mRNA in all groups except K0 (p<0.05). Notably, after 3 weeks of BE administration, 
caspase-3 mRNA expression was significantly decreased in all BE-treated groups; in the K1 placebo group, caspase-3 mRNA expression increased. The 
maximum decreased caspase-3 mRNA expression was in group K4 (-BE 1000 mg/kg BW), and the minimum was in group K2 (-BE 250 mg/kg BW).
Conclusion: The results revealed that the ethanolic extract of MPL fruit could decrease caspase-3 mRNA gene expression in AD rat
Keywords: Alzheimer’s disease, Intracerebroventricularly, Amyloid beta, Caspase-3, Musa paradisiaca L.
INTRODUCTION
Alzheimer’s disease (AD) is an irreversible and progressive 
neurodegenerative disease, a form of dementia known globally, 
projected that, by 2050, about 115 million people will be affected 
worldwide [1]. As the aging population increases, the number of 
patients with AD also increases, with a rate of 13% in older patients 
over 65 years old and 45% in the group aged over 85 years old [2]. 
The majority of AD cases occur in women compared with men, and 
the estimated risk for developing AD is about 20% for women and 
10% for men age above 65 [3]. AD was initially discovered by German 
neural expert Alois Alzheimer in 1906, who found brain lesions that 
lead to dementia and they were highly associated with strokes, brain 
tumor, and degenerative diseases [4]. Several factors contribute to the 
progression of the disease including amyloid-beta (Aβ) accumulation, 
neurofibrillary tangle formation, cholinergic deficit, oxidative stress, 
neuroinflammation, and apoptosis [5].
Apoptotic signaling is classified as proceeding by either an intrinsic 
pathway or an extrinsic pathway. The intrinsic apoptotic signaling 
is most often induced by the intracellular damage that leads to the 
mitochondrial release of cytochrome c and the activation of intracellular 
cysteine proteases called caspases [6]. Extrinsic apoptotic signaling 
is initiated by stimulation of plasma membrane death receptors 
that initiate apoptosis by activation of caspase-8, and subsequent 
apoptotic signaling can proceed through the mitochondrial pathway 
or independently of mitochondria by caspase-8-mediated direct 
activation of caspase-3 [7]. Caspase-3 acts as a caspase executor in 
the apoptosis process [8]. Caspase-3 appears to be the major effector 
in neuronal apoptosis triggered by various stimuli. The first strong 
evidence supporting the specific role for this protease in neuronal 
apoptosis comes from studies on mice deficient in caspase-3 in which 
brain development is profoundly altered [9]. Furthermore, Aβ secretion 
decreased when there is an obstacle to its production in caspase-3 
caused by antioxidant and pramipexole [10]. The drugs designed to 
slow disease progression are available. Some medicinal herbs from 
plants may help to improve brain function, but scientific evidence to 
prove that they can treat AD is limited.
Commenges et al. found that an intake of flavonoids significantly reduced 
the risk of dementia [11]. In this research, caspase-3 mRNA gene 
expression in an AD rat model induced by injection of Aβ for 6 weeks, 
which was treated with banana extract (BE)/Musa paradisiaca L. (MPL) 
for 3 weeks, was evaluated. The purpose of this study was to analyze the 
effect of BE (MPL) administration on the expression of the caspase-3 
mRNA gene in the Wistar rats model of AD, with the hypothesis that 
BE MPL administration for 3 weeks can decrease the expression of the 
caspase-3 mRNA gene in Wistar rats which is in Aβ induction for 6 weeks. 
BE referred to herein is BE or MPL which is extracted using ethanol.
METHODS
Materials
Experimental procedures were carried out in the Molecular 
Microbiology and Immunology Laboratory, Medical Faculty University 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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of Hasanuddin, Makassar, Indonesia. This research was an experimental 
study in vivo pre- and post-design that was conducted from February to 
July 2016. The research has been approved by the Medical and Health 
Research Ethics Committee, Medical Faculty University of Hasanuddin, 
Makassar, Indonesia (Number: 391/H4.8.4.5.31/PP36-KOMTIK/2016).
Animals
Animal preparation
Twenty Wistar rats (2.5–3 months, 150–250 g) were maintenance at 
Animal Laboratory, Molecular Biology and Immunology Laboratory, 
Medical Faculty University of Hasanuddin, Makassar, Indonesia, for 
this study. The rats were randomly assigned to one of five groups (=4 
in each group): The control (K0 and K1) and treatment groups (K2, 
K3, and K4). They were kept for 1 week for proper acclimatization 
before starting the experiment under the controlled condition of 
illumination (12 h light/12 h darkness) and temperature 23±2°C. They 
were housed under ideal laboratory conditions and maintained on the 
standard pellet diet and water ad libitum throughout the experimental 
period. All procedures were by the internationally accepted guideline 
for experimental animal use and care of Animals Laboratory of the 
Molecular Microbiology and Immunology Laboratory, Medical Faculty 
University of Hasanuddin, Makassar.
Experimental design
In this study, total number of twenty Wistar rats were divided into 
following five groups having four rats in each group: K0=no induction AD 
model and no BE MPL administration; K1=AD induction model without 
BE MPL administration (just given a placebo); K2=AD induction model 
with 250 mg/kg body weight (BW) BE MPL administration; K3=AD 
induction model with 500 mg/kg BW BE MPL administration; and 
K4=AD induction model with 1000 mg/kg BW BE MPL administration. 
Caspase-3 mRNA expression was assessed before AD induction, 
6 weeks after AD induction, and 3 weeks post-BE MPL administration.
Administration of MPL ethanol extract BE
Banana fruits were obtained from a market in Bogor, West Java 
Province, Indonesia. The fruits were cut longitudinally into chips of 
about 5–10 mm thickness and then dried in an oven after which they 
were ground and added ethanol (95%) to a conical flask and then 
shaken every 30 min (for 6 h) and sterilized for 48 h. The solution is 
then filtered using filter paper, ethanol added to the solution coming 
out of the colorless outer macerator (usually 5–6 times immersion) 
and then concentrated using a rotary evaporator until no more solvent, 
which drips on the rotary evaporator condenser. This is called solid 
dry extract and is used in this study. Three doses of the plantain flour 
were prepared: 250 mg/kg/day, 500 mg/kg/day, and 1000 mg/kg/day. 
The flour was dissolved in 2 ml of double-distilled water, for easy 
administration. Banana MPL ethanol extract or BE was obtained by 
maceration methods at Balitro Bogor Agricultural Department 
Laboratory, West Java Province, Indonesia, and plant determination 
process from Central Biology Research, Bogor LIPI, West Java Province, 
Indonesia (Number: 147/IPH.1.02/lf.07/I/2016). Previous research 
by Ittiyavirah and Anurenj showed that a 200 mg/kg BW dose of MPL 
ethanol extract BE given over 21 days produced a significant effect on 
anti-stress activity [12]. In the study for this AD, we increased the dose 
to 250 mg/kg, and the BE used on K2 is 250 mg/kg BW, K3 500 mg/kg 
BW, and K4 1000 mg/kg BW for experimental analyses; treatments 
were given orally for 21 days (3 weeks) each day. While in K1 only given 
a placebo with the same time of administration is 3 weeks. Overall, both 
BE MPL and placebo were administered by mouth-feeding.
Animal model
In this research, we do advance preliminary research which was done to 
develop an animal model of the AD. To develop an AD model, we used a 
dose of Aβ1-42 of 0.2 μg injected in intracerebroventricular and observed 
the mice for 6 weeks, and Aβ levels were measured using the SAA Mouse 
Elisa Kit. The AD animal model was generated using Aβ1-42 peptide from 
Abcam, code number.Ab120959 (Cambridge, MA, USA) [13], which is a 
reference modeling AD protocol.
Blood collection
Blood samples were collected at three time points: Day 0 before Aβ 
injection (baseline); day 42 (week: 6), i.e., on the last day of post-AB 
induction observation or the day before the MPL intervention; and last 
is the day 63, the last day of BE intervention which done in 21 days from 
day 42 (weeks: 9, changes). Blood was taken from the tail vein using a 
0.1 ml hematocrit needle. The samples were centrifuged and were kept 
in a sterile tube at −20°C until analyses.
Real time-polymerase chain reaction (RT-PCR)
The RT-PCR Method uses the Boom method, which has high 
sensitivity and specificity for disease diagnosis. In the extraction of 
DNA, the materials used are diatoms, L6 (lysis buffer), L2 (washing 
buffer), and TE (elution buffer). The diatoms have large contours 
that will bind DNA. While L6 serves as a lysis buffer and L2 as a 
washing buffer, and Tris EDTA (TE) to bind DNA out of diatoms. 
The RT-PCR was carried out to determine the levels of caspase-3 
mRNA gene expression. RT-PCR was performed with the following 
primers, caspase-3 forward: 5’-AGCTTCTTCAGAGGCGACTA-3’ 
and reverse: 5’-GGACACAATACACGGGATCT-3’ [15]; and 
glycerol-aldehyde-3-phosphate dehydrogenase (GAPDH) 
forward: 5’-CTCAAGATTGTCAGCAATGC-3’ and reverse: 
5’- CAGGATGCCCTTTAGTGGGC-3’ [16]; reactions were performed 
using the one-step RT-PCR kit (Macrogen, Korea), GADPH was used 
as an internal control. Primers for RT-PCR were designed using Oligo 
software (Bio-Rad CFX Manager). The blood samples from treatment 
and control in homogenization and total RNA samples in extraction 
according to the instructions of the protocol. Reactions were visualized 
by agarose gel electrophoresis analysis. Rate threshold cycle in the 
calculation of the standard software. The level of expression exraction 
according to the instructions of the protocol. Making PCR mix: using 
solution (Table 1), for caspase-3 made in triplicate. Then take 5.2 μl 
caspase-3 into each well (each well requires a 5.2 μl PCR mix). Also, 
distribute GAPDH (as standard) into the wells, each well needs a 5.2 μl 
PCR mix. Here, fill the samples in the wells each containing the PCR mix, 
caspase-3, and GAPDH, wait for 1.5 h. Then, turn on the PCR tool and 
make a layout, then input the sample that has been idle for 1.5 h into the 
wells, each enter as much as 5.2 μl, neither with the standard (GAPDH). 
Next is dilution: 20 μ RNA free water inserted into the new tube (tubes 
1, 2, 3, 4, 5, and 6), then the DNA template of all samples takes as much 
as 20 μ and diluted with 20 μ which had been diluted and so on up to the 
six tubes. Then, enter 5 μ to the wells that have been made earlier, close 
and insert into the PCR machine, perform an initial denaturation stage 
of 96°C for 3 min, next 95°C for 30 s, next annealing 55°C for 30 s with 
volume contents 5+5=10 μ 40 times.
Statistical analysis
The data caspase-3 mRNA gene expression was statistically analyzed 
and the significance calculated using one-way “ANOVA” (Bonferroni) 
followed by Tukey’s test. All numerical values were expressed as a 
mean±standard deviation and the value of p<0.05 was considered as 
statistically significant.
Fig. 1 Schematic of the research process. Twenty Wistar rats were divided 
into 5 groups: K0=no induction AD model and no BE administration; 
K1=AD induction model without BE administration; K2=AD induction 
model with 250 mg/kg BW BE administration; K3=AD induction model 
with 500 mg/kg BW BE administration; and K4=AD induction model 
with 1000 mg/kg BW BE administration. Caspase-3 mRNA expression 
Table 1: Stages of PCR mix manufacturing
RT-PCR Caspase-3 (×80) GAPDH (×30)
Master mix=2.5 µl 200 µl 75 µl
Free water=2.5 µl 200 µl 75 µl
Primer Caspase-3 F=0.1 µl 8 µl 3 µl
Primer Caspase-3 R=0.1 µl 8 µl 3 µl
Template=5 µl
RT-PCR: Real time-polymerase chain reaction
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was assessed before AD induction, 6 weeks after AD induction, and 
3 weeks post-BE administration.
RESULTS
In this study, we examined the effects of MPL administration at various 
doses in an AD animal model. The schematic of our research strategy 
is shown in Fig. 1. The levels of caspase-3 mRNA at various time 
points throughout the analysis were evaluated. The caspase-3 mRNA 
expression levels in all observation groups are summarized in Table 2
Paired t-test and one-way ANOVA (Bonferroni) showed changes in 
caspase-3 mRNA expression after 6 weeks post-induction Aβ, and no 
significant differences in caspase-3 mRNA expression among all five 
groups before induction were observed (p>0.05). At 6 weeks post-
induction Aβ, there was a significant increase (p<0.05) in caspase-3 
mRNA expression in all groups except the K0 group. There were no 
significant differences in the increase in caspase-3 mRNA expression 
among induction groups (p>0.05). At 6 weeks after induction Aβ, we 
detected increased caspase-3 mRNA expression in the induction Aβ 
groups, while no changes occurred in the non-induction Aβ group (K0).
Paired t-test and one-way ANOVA (Bonferroni) were used to examine 
changes in caspase-3 mRNA expression after 3 weeks post-BE admission, 
and after 3 weeks of BE administration, there was a significant increase 
in caspase-3 mRNA in the group without BE (placebo) compared with 
the levels at week 6 before BE treatment (p<0.05). Notably, in all groups 
receiving BE, all showed a significant decrease in caspase-3 mRNA 
expression compared with the levels at week 6 before BE treatment 
(p<0.05). After 3 weeks of BE admission during the post-induction 
period, caspase-3 mRNA expression decreased in all groups given BE. In 
comparison, in the group given the only placebo, the caspase-3 mRNA 
levels continued to increase. The maximum decrease in caspase-3 
mRNA expression was observed in the K4 group, which received a BE 
dosage of 1000 mg/kg BW. The smallest decrease was observed in 
group K2, which received a BE dosage of 250 mg/kg BW.
DISCUSSION
Despite extensive investigations, the mechanism activating apoptotic 
pathways or neuronal degeneration in the AD has not been completely 
understood. In the present study, we showed the effects of administration 
of MPL extract BE on caspase-3 mRNA expression in Aβ-induced AD 
rats. Our results show that: (i) in both K1 (placebo) and K2, K3 and K4 
before MPL- detected treatment intervention experienced an increase 
in caspase-3 mRNA expression at 6 weeks after induction of Aβ, which 
is similar to the result presented by cetin  et al. Their research found 
high caspase-3 activity levels in hippocampus, temporal, and parietal 
cortex in aged mice injected with Aβ1-42 [17]. Aβ has been proposed as 
the main factor in the AD pathophysiology mechanism and the major 
Table 2: Caspase-3 mRNA expression in each group




6 weeks after 
induction (weeks 6)









K0 (n=4) 7.68 (0.25)A 7.66 (0.23)A 7.64 (0.06)A 0.900 0.871
K1 (n=4) 7.65 (0.07)A 12.69 (0.16)B 13.67 (0.16)B <0.001 0.007
K2 (n=4) 7.54 (0.38)A 12.49 (0.07)B 11.54 (0.05)D <0.001 <0.001
K3 (n=4) 7.63 (0.07)A 12.73 (0.15)B 9.23 (0.18)C <0.001 <0.001
K4 (n=4) 7.68 (0.10)A 12.53 (0.04)B 8.65 (0.10)C <0.001 <0.001
Values are mean±SD. Statistics+one-way ANOVA followed by Bonferroni post hoc test, *p>0.05 versus KO, *p<0.05 versus K1, *p<0.05 versus K2, *p<0.05 versus K3, 
*p<0.05 versus K4. N=Number of rats in each group, BE: Banana extract, SDM=Standard deviation mean
Fig. 1: Outline of research process
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component of senile plaques, is considered to play a central role in 
neuronal cell death (apoptosis), and has received the most attention 
[18]. This has been demonstrated in neurons of human and rodent 
brains. In patients suffering from neurodegenerative disorders such as 
AD, PD, and amyotrophic lateral sclerosis, there is a prominent increase 
in the neuronal RNA damage when compared to normal aging people 
[19]. Several factors that are assumed to contribute in AD pathogenesis, 
such as the role of key proteins, oxidative damage, mitochondrial 
dysfunction, and the cholinergic hypothesis [20]. The role of neuronal 
cell death (apoptosis) includes caspase-9 and caspase-3 [21]. Our next 
findings in this study are (ii) that the placebo group continued to show 
significantly increased caspase-3 mRNA levels for the next 3 weeks. 
However, in groups treated with MPL BE, we observed the opposite 
trend, with a significant decrease of caspase-3 mRNA expression 
(p<0.05). The maximum decreased level of caspase-3 mRNA expression 
was observed in K4, the group which received the highest dose of MPL 
BE in this study (1000 mg/kg BW BE), and the minimum decrease was 
observed in group K2, which received 250 mg/kg BW BE. This result is 
consistent with the study by Vijayakumar et al., who reported findings 
of flavonoid antioxidant MPL activity in mice [22]. The antioxidant 
activity of the extracted flavonoids from M. paradisiacal in rats 
stimulated the activities of superoxide dismutase and catalase which 
might be responsible for the reduced level of peroxidation products 
such as malondialdehyde, hydroperoxides, and conjugated dienes [22].
The authors stated that flavonoids could modulate the expression of 
several genes through activation of many transcription factors and act 
as a neuroprotection agent, were thought to work by modulating kinase 
proteins, and act as a kinase cascade lipid signal, such as phosphatidyl 
inositol-3 kinase (PI3K)/Akt pathway signal, tyrosine kinase, protein 
kinase C (PKC) and mitogen-activated protein kinase (MAPK), and 
PKB [23]. Activation of neuronal cell membrane receptors may result 
in caspase activation, enhanced calcium levels, and the generation 
of reactive oxygen species (ROS), both are known to contribute to 
the mitochondrial pathway, including B-cell lymphoma 2 (Bcl-2) 
proteins, high intracellular calcium levels. and ROS. On entering 
the cytoplasm, cytochrome c forms an apoptosomal complex with a 
procaspase, adenosine triphosphate, and apoptotic protease activating 
factor 1 (Apaf-1), an Apaf-1 [21]. The apoptotic pathway is generally 
characterized by various signals including mitochondrial release from 
proapototic molecules such as Bcl-2, ROS, high calcium and cytochrome 
C binds Apaf-1 and procaspase 9 to form apoptosomes, which further 
activate caspase 9nd procaspase 9 to form the apoptosome, thereby 
activating caspase 9. Caspase-9 activates caspase-3, ultimately leading 
to cell death [24]. Heo et al. used BE MPL to protect neurons from 
oxidative stress by neurotoxicity. The study also showed that BE 
MPL could reduce oxidative stress risk caused by neurodegenerative 
diseases, such as AD [22]. The BE possess very good radical scavenging 
activity and as well the largest amount of phenolic contents, which could 
introduce phenols as the main radical scavenger in BE and offering 
effective protection from free radicals and the antioxidant activity [25]. 
The difference with the previous research that they only see MPL on 
oxidative stress and as an antioxidant, but in this study, emphasized 
its effect on the expression of the caspase-3 mRNA gene. We add the 
biochemical evidence showing that treatment with ethanolic extract 
MPL can decrease serum expression of caspase-3 mRNA in an animal 
model for the AD, suggesting that it may prevent cell apoptosis. Further 
studies are required to isolate and evaluate individual phytoconstituents 
in MPL for their neuroprotection potential.
CONCLUSION
Taking together, it may finally be concluded that Aβ-induced AD causes 
neuron cell death, where apoptosis plays an important role in it and 
may be inhibited by flavonoids, may exert regulatory activities in cells 
through actions such as cyclin-dependent kinases, caspases, Bcl-2 family 
members, epidermal growth factor/epidermal growth factor receptor, 
phosphatidylinositol-3-kinase/Akt, MAPK, and include the inhibition of 
c-Jun N-terminal kinases and p38 pathways and the activation of PI3-K/
Akt, and PKC pathways in different type of cell such as neuronal, cardiac, 
endothelial, epithelial, hepatocytes, and macrophages. Such interactions of 
flavonoids with cell signaling pathways provide various beneficial effects 
such as improving brain function, preventing oxidative stress, preventing 
apoptosis, protecting against endothelial barrier dysfunction and injury, 
improving the cognitive function, decreasing the neurodegeneration, and 
stimulating endothelial NOS activity. That natural flavonoids can inhibit 
caspase-3 activity. Medication using MPL ethanol extract can decrease 
caspase-3 mRNA expression in AD rats. Suggesting that these flavonoids 
may be useful which leads to the rational design of non-peptidic, caspase-
specific inhibitors for therapeutic use. Herbs may play a promising role in 
the early treatment of Alzheimer’s and other conditions involving poor 
memory and dementia. One of the chief benefits is that they have a low 
side effect compared to pharmaceutical agents.
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